BIOMAT Database Logo BIOMAT Database Logo

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. 1994

M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.

Beta-2-GPI is a 50 kDa glycoprotein which is known to be a serum co-factor, with a role in determining the binding of pathogenic anticardiolipin antibodies to phospholipids. Immunization of naive mice with beta-2-GPI resulted in elevated levels of antibodies directed against negatively charged phospholipids (cardiolipin, phosphotidylserine, phosphatidylinositol). The presence of increased titres of antiphospholipid antibodies in the sera of the mice was later followed by prolonged activated partial thromboplastin time (APTT), thrombocytopenia, and when the mice were mated, by a high percentage of fetal resorptions in the uterus. These data point to the ability of beta-2-GPI to induce pathogenic anti-cardiolipin antibodies following active immunization.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005327 Fetal Resorption The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS). Fetal Resorptions,Resorption, Fetal,Resorptions, Fetal
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
January 1992, Autoimmunity,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.
October 1994, Arthritis and rheumatism,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Expression of human recombinant beta 2-glycoprotein I with anticardiolipin antibody cofactor activity.
July 1993, FEBS letters,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
beta 2-Glycoprotein I and antiphospholipid syndrome.
April 1997, Israel journal of medical sciences,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.
May 1996, Thrombosis and haemostasis,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Antiphospholipid antibodies require beta 2-glycoprotein I (apolipoprotein H) as cofactor.
September 1992, The Journal of rheumatology,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
August 1999, Human reproduction (Oxford, England),
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome.
November 2000, Journal of autoimmunity,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and beta 2-glycoprotein-I plasma levels.
July 1992, European journal of clinical investigation,
M Blank, and D Faden, and A Tincani, and J Kopolovic, and I Goldberg, and B Gilburd, and F Allegri, and G Balestrieri, and G Valesini, and Y Shoenfeld
Cofactor (beta 2-glycoprotein 1) dependent anticardiolipin antibodies and thrombosis.
July 1994, The Journal of rheumatology,
Copied contents to your clipboard!